Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abnormal back muscle activity in cervical dystonia
2022-002192-11Phase 4Active
- Sponsor
- Pirkanmaa Hospital District
- Start
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of neuronox in cervical dystonia (CD) (2 arms), sponsored by Pirkanmaa Hospital District. Primary endpoint: Change in dystonia severity (UDRS). Started Oct 2022; status: active.
02
Drugs
neuronox
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on 2022-002192-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002192-11.